Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019 provides an overview of Central Nervous Systems Therapeutic Drug Monitoring currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Nervous Systems Therapeutic Drug Monitoring pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Central Nervous Systems Therapeutic Drug Monitoring under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Nervous Systems Therapeutic Drug Monitoring and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Nervous Systems Therapeutic Drug Monitoring under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date


  • Introduction
    • Central Nervous Systems Therapeutic Drug Monitoring Overview
  • Products under Development
    • Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Figure 1: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
    • Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
      • Table Figure 2: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
      • Table Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
    • Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
      • Table Figure 3: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
      • Table Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
    • Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
      • Table Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
  • Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
    • Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
      • Table Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
    • Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
  • Central Nervous Systems Therapeutic Drug Monitoring Companies and Product Overview
    • Abbott Diagnostics Company Overview
      • Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alinity c Assay - Carbamazepine - Product Status
        • Table Alinity c Assay - Carbamazepine - Product Description
    • ARK Diagnostics Inc Company Overview
      • ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARK High Sensitivity Benzodiazepines Assay - Product Status
        • Table ARK High Sensitivity Benzodiazepines Assay - Product Description
        • Table ARK High Sensitivity Opiates Assay - Product Status
        • Table ARK High Sensitivity Opiates Assay - Product Description
        • Table ARK Tiagabine Assay - Product Status
        • Table ARK Tiagabine Assay - Product Description
        • Table ARK Zolpidem Assay - Product Status
        • Table ARK Zolpidem Assay - Product Description
        • Table ARK Zopiclone Assay - Product Status
        • Table ARK Zopiclone Assay - Product Description
    • Avacta Group Plc Company Overview
      • Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Depression Test - Product Status
        • Table Depression Test - Product Description
        • Table Diagnostic Assay - Alzheimer's Disease - Product Status
        • Table Diagnostic Assay - Alzheimer's Disease - Product Description
        • Table Diagnostic Test - ADHD - Product Status
        • Table Diagnostic Test - ADHD - Product Description
        • Table Diagnostic Test - Bipolar Disorder - Product Status
        • Table Diagnostic Test - Bipolar Disorder - Product Description
        • Table Schizophrenia Response Test - Product Status
        • Table Schizophrenia Response Test - Product Description
    • ELITechGroup Inc Company Overview
      • ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eon 100 Automated Chemistry Analyzer - Phenobarbital - Product Status
        • Table Eon 100 Automated Chemistry Analyzer - Phenobarbital - Product Description
        • Table Eon 100 Automated Chemistry Analyzer - Phenytoin Assay - Product Status
        • Table Eon 100 Automated Chemistry Analyzer - Phenytoin Assay - Product Description
        • Table Eon 300 Automated Chemistry Analyzer - Phenobarbital Assay - Product Status
        • Table Eon 300 Automated Chemistry Analyzer - Phenobarbital Assay - Product Description
        • Table Eon 300 Automated Chemistry Analyzer - Phenytoin Assay - Product Status
        • Table Eon 300 Automated Chemistry Analyzer - Phenytoin Assay - Product Description
    • Nipro Europe N.V. Company Overview
      • Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lithium Assay - Product Status
        • Table Lithium Assay - Product Description
    • Pax Neuroscience Inc Company Overview
      • Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Test - Antidepressant Efficacy - Product Status
        • Table Blood Test - Antidepressant Efficacy - Product Description
    • Saladax Biomedical Inc Company Overview
      • Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MyCare Paliperidone Assay Kit - Product Status
        • Table MyCare Paliperidone Assay Kit - Product Description
    • Siemens Healthineers AG Company Overview
      • Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table ADVIA Chemistry XPT System - Gabapentin Assay - Product Status
        • Table ADVIA Chemistry XPT System - Gabapentin Assay - Product Description
        • Table ADVIA Chemistry XPT System - Lamotrigine Assay - Product Status
        • Table ADVIA Chemistry XPT System - Lamotrigine Assay - Product Description
        • Table ADVIA Chemistry XPT System - Levetiracetam Assay - Product Status
        • Table ADVIA Chemistry XPT System - Levetiracetam Assay - Product Description
        • Table ADVIA Chemistry XPT System - Topiramate Assay - Product Status
        • Table ADVIA Chemistry XPT System - Topiramate Assay - Product Description
        • Table ADVIA Chemistry XPT System - Zonisamide Assay - Product Status
        • Table ADVIA Chemistry XPT System - Zonisamide Assay - Product Description
    • University of Colorado Company Overview
      • University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Assay - Schizophrenia - Product Status
        • Table Biomarker Assay - Schizophrenia - Product Description
  • Central Nervous Systems Therapeutic Drug Monitoring- Recent Developments
    • Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
    • Jul 29, 2019: Siemens Healthineers continues to drive growth forward
    • Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
    • May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
    • Apr 09, 2019: Avacta Group: Interim results for the period ended 31 January 2019
    • Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
    • Jan 28, 2019: Avacta Group names Dr. Sam Williams as Non-Executive Director to the Board
    • Jan 21, 2019: Avacta Group announced its AGM business update and notice of results
    • Dec 12, 2018: Avacta Group names Dr. Jose Saro as Chief Medical Officer
    • Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
    • Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed
    • Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved
    • Oct 23, 2018: Leading Homegrown Medical Group, MWH Medical partners Siemens Healthineers to launch region's first Asia Reference Centre
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook